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a b s t r a c t
Combinations of anthelmintics with a similar spectrum of activity and different mecha-
nisms of action and resistance are widely available in several regions of the world for the
control of sheep nematodes. There are two main justiﬁcations for the use of such com-
binations: (1) to enable the effective control of nematodes in the presence of single or
multiple drug resistance, and (2) to slow the development of resistance to the component
anthelmintic classes. Computer model simulations of sheep nematode populations indi-
cate that the ability of combinations to slow the development of resistance is maximised
if certain prerequisite criteria are met, the most important of which appear to concern
the opportunity for survival of susceptible nematodes in refugia and the pre-existing lev-
els of resistance to each of the anthelmintics in the combination. Combinations slow the
development of a resistant parasite population by reducing the number of resistant geno-
types which survive treatment, because multiple alleles conferring resistance to all the
component anthelmintic classes must be present in the same parasite for survival. Indi-
viduals carrying multiple resistance alleles are rarer than those carrying single resistance
alleles. This enhanced efﬁcacy leads to greater dilution of resistant genotypes by the uns-
elected parasites in refugia, thus reducing the proportion of resistant parasites available
to reproduce with other resistant adults that have survived treatment. Concerns over the
use of anthelmintic combinations include the potential to select for resistance to multiple
anthelmintic classes concurrently if there are insufﬁcient parasites in refugia; the potential
for shared mechanisms of resistance between chemical classes; and the pre-existing fre-
quency of resistance alleles may be too high on some farms to warrant the introduction of
certain combinations. In conclusion, anthelmintic combinations can play an important role
in resistance management. However, they are not a panacea and should always be used in
accordance with contemporary principles for sustainable anthelmintic use.
© 2011 Elsevier B.V. Open access under CC BY-NC-ND license.
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1. Background
The status of anthelmintic resistance (AR) in small rumi-
nants has been reviewed by others (Besier and Love, 2003;
Kaplan, 2004; Wolstenholme et al., 2004; Jabbar et al.,
2006). AR is a global problem that poses a signiﬁcant threat
to the production and welfare of grazing livestock (Waller,
2006; Besier, 2007). Of particular concern is the escalat-
ing level of resistance to the macrocyclic lactones (MLs),
and reports of multiple resistance (van Wyk  et al., 1989,
1999; Wooster et al., 2001; Love et al., 2003; Yue et al.,
2003; Bartley et al., 2004, 2005; Hughes et al., 2005, 2007;
Waghorn et al., 2006; Sargison et al., 2007; Sutherland
et al., 2008; Wrigley et al., 2006). Anthelmintic treatment
provides a survival advantage for parasites carrying resis-
tance alleles. Surviving parasites pass these alleles to their
offspring so the allele frequency increases during subse-
quent parasite generations if selection is maintained. It is
generally considered that anthelmintic resistance develops
through the selection of ancient resistance alleles present
in the parasite population (Gilleard and Beech, 2007). How-
ever, spontaneous recent mutations, which may  occur
recurrently, and the introduction of resistance alleles as
a consequence of movement of hosts, may  also play an
important role (Gilleard and Beech, 2007).
In this context, the administration of combinations
of anthelmintics with a similar spectrum of activity and
different mechanisms of action and resistance has been
suggested as a potential means of delaying the develop-
ment of AR (Anderson et al., 1988, 1991; McKenna, 1990;
Smith, 1990; Coles and Roush, 1992; Barnes et al., 1995;
Leathwick et al., 2009). For the purposes of this paper, the
term ‘combinations’ refers to formulations that are a mix-
ture of two or more distinct classes of anthelmintics with a
similar spectrum of activity, rather than the combinations
formulated to provide broad spectrum control of parasites
from different phyla, e.g. nematodes and tapeworms or
nematodes and liver ﬂuke. The former combinations are
commercially available in Australia, New Zealand, South
Africa and Latin America and include dual combinations
of levamisole (LV) + ML,  or LV + benzimidazole (BZ), or
derquantel + ML,  or triple combinations of BZ + LV + ML.
There are two main justiﬁcations for the use of combi-
nations: (1) to enable the effective control of nematodes
in the presence of single or multiple drug resistance,
and (2) to slow the development of resistance to the
component anthelmintic classes (Leathwick et al., 2009).
The rationale for using drug combinations to delay the . .  .  . .  . . . . .  . .  . . .  .  . . .  . . . .  . .  . . . .  .  . . .  .  . . . . . . .  .  . . . . . .  . . .  . . . .  .  . . .  . . . .  . 156
development of AR was  initially inspired by research into
insecticide resistance. Results from several modelling stud-
ies with insecticides suggested that combinations were
always more effective at delaying the development of resis-
tance than using the same actives in different patterns of
rotation (alternating the use of different chemical classes)
or sequentially (where one chemical class is used exclu-
sively until resistance develops and its use is then replaced
by the introduction of a different chemical class) (Wood
and Mani, 1981; Curtis, 1985; Mani, 1985; Comins, 1986).
Conversely, results from other studies seemed to suggest
that combinations offer few advantages in slowing the
development of resistance and may  even be worse than
single pesticide strategies under some conditions (Roush,
1989; Tabashnik, 1989). Nevertheless, results from all of
these studies supported the concept that the use of insecti-
cides in combination can greatly extend the effective life of
the constituent chemicals, provided certain conditions are
met.
Potential pharmacodynamic interactions between co-
administered anthelmintics include: indifference, antag-
onism, additive or synergistic effects. (Entrocasso et al.,
2008). An additive effect occurs when the combined effect
of two  drugs equals the sum of their independent activities
measured separately (Entrocasso et al., 2008). For exam-
ple, if co-administered actives have independent modes
of action and mechanisms of resistance, nematodes which
survive one treatment will be killed by the other, provided
they are not multi-resistant. The expected efﬁcacy of an
anthelmintic combination can be approximated using the
fractional product method (Webb, 1963) which deﬁnes the
additive effect of two independently acting agents as the
product of the unaffected survival fractions after treatment
with either agent alone. That is, if two anthelmintics have
efﬁcacies a and b respectively, where efﬁcacy is expressed
as the proportion of worms killed, the expected efﬁcacy for
the combination, assuming additive effects of the drugs, is
given as: efﬁcacy (A + B) = 1 − ((1 − a) × (1 − b)). By contrast,
a synergistic effect is present if the response obtained after
their combined administration is greater than additive.
Possible synergistic interactions between anthelmintics
have been reported (Anderson et al., 1991; Miller and
Craig, 1996). Evidence indicative of additive effects can be
observed from the efﬁcacy data reported in several stud-
ies (e.g. Anderson et al., 1988; McKenna, 1990; Anderson
et al., 1991; Pomroy et al., 1992; Bartley et al., 2004,
2005; Entrocasso et al., 2008; Le Jambre et al., 2010). This
means that combinations achieve higher efﬁcacy against
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esistant parasite populations than do either of the com-
onent anthelmintics used alone, and fewer resistant par-
sites survive treatment. The survivors are then diluted by
nselected parasites in refugia (van Wyk, 2001). The princi-
le of additive effects is widely accepted and is applied, for
xample, in the recommendation for quarantine treatment
f introduced stock in the United Kingdom, which involves
he sequential administration in close succession of two
nthelmintics from different chemical classes (Abbott et al.,
009).
Drug combinations are also increasingly used in human
edicine to delay the development of drug resistance
n, for example, malaria parasites. Combinations such
s artemisinin combination therapy (ACT), delay the
mergence of resistance because one component of the
ombination eliminates parasites with alleles that confer
esistance one or more of the other components; alle-
es conferring resistance to all components must arise in
he same parasite for it to survive. Combination therapies
hus delay the time until a viable resistant parasite pop-
lation develops (White and Olliaro, 1996; Smith et al.,
010; Hastings, 2011). Indeed, the use of artemisinin as a
onotherapy is explicitly discouraged by the World Health
rganization (WHO). They recommend that a combina-
ion of artemisinin or one of its derivatives with one or
ore antimalarials of a different class is used as ﬁrst-
ine treatment of uncomplicated Plasmodium falciparum
alaria, speciﬁcally to delay the development of resis-
ance (WHO, 2010). The current prevailing opinion is
hat combination therapy is the most appropriate way
o manage resistance in malaria and that anti-malarial
onotherapy should be consigned to history (Hastings,
011).
. Prerequisite conditions to slow resistance
evelopment
Early work on the use of combinations to slow resistance
evelopment focused on pesticides for crop protection,
nd six conditions have been identiﬁed under which com-
inations will be most effective (Leathwick et al., 2009).
hese are: (1) resistance to different chemical classes
f pesticide is under independent genetic control, i.e.
o cross-resistance; (2) resistance alleles are functionally
ecessive under treatment; (3) there is a low frequency of
esistance alleles; (4) the efﬁcacy of each of the compo-
ent pesticides against susceptible genotypes approaches
00%; (5) a proportion of the population is not exposed
o treatment to ensure that surviving resistant genotypes
re diluted in a pool of susceptible genotypes; and (6)
he pesticides used have a similar duration of action so
hat all components are effective throughout the dura-
ion of efﬁcacy of the combination (Wood and Mani,
981; Curtis, 1985; Mani, 1985; Comins, 1986; Roush,
989). Importantly, these conditions interact so that all
re not universally required for a combination to be effec-
ive in slowing the development of resistance (Wood and
ani, 1981). The question then becomes whether the
onditions required to achieve the potential beneﬁt fromitology 186 (2012) 151– 158 153
combinations are likely to occur in the context of the use of
anthelmintics to control nematode parasites of livestock.
2.1. Resistance to different chemical classes is under
independent genetic control
It is generally accepted that the mechanisms of resis-
tance to BZ, LV and ML  are different (Mottier and Prichard,
2008), and that there is virtually no cross-resistance
between them (Coles and Roush, 1992). Evidence is
provided by data demonstrating higher efﬁcacy of one
anthelmintic class against nematode populations resis-
tant to other classes (Echevarria et al., 1991), or by the
additive effects of anthelmintics when different classes
are administered in combination (Anderson et al., 1988,
1991; McKenna, 1990; Pomroy et al., 1992; Bartley et al.,
2004, 2005; Entrocasso et al., 2008; Le Jambre et al.,
2010). Evidence has been presented that repeated selec-
tion of Haemonchus contortus with ML  anthelmintics can
cause allelic changes in the -tubulin isotype 1 gene, the
key locus involved in the mechanism of BZ resistance
(Mottier and Prichard, 2008), but it is far from clear whether
these ﬁndings represent true cross-resistance (Leathwick
et al., 2009). Moreover, computer simulation indicates that
a degree of cross-resistance between two  anthelmintic
classes does not necessarily negate the beneﬁt of using
actives in combination compared with using them sepa-
rately either sequentially or in rotation (Leathwick, 2011).
Indeed, the development of resistance was  delayed when
both drugs were used in combination even in the presence
of a common allele which was selected for by both drugs.
2.2. Resistance alleles are functionally recessive under
treatment
Resistance to BZ, LV and ML  is generally regarded
as being recessive, or partially recessive (Martin and
McKenzie, 1990; Dobson et al., 1996; Prichard, 2001;
Sutherland et al., 2002; Le Jambre et al., 2005), with the
notable exception of ivermectin resistance which behaves
as a dominant trait in some parasites (Le Jambre et al.,
2000; Sutherland et al., 2002). When resistance is func-
tionally dominant under pesticide treatment, it has been
suggested that the use of combinations will result in the
rapid build-up of resistance due to linkage disequilibrium
(Curtis, 1985). However, when treatments were stopped for
several generations the associated resistance alleles were
rapidly re-assorted and disequilibrium disappeared. The
non-random accumulation of resistance genotypes in Cur-
tis’s model was  inﬂuenced by the assumption that 90% of
each insect generation was exposed to treatment prior to
mating and hence there was  relatively little opportunity
for resistant genotypes to be broken up by mating with
susceptible genotypes. This conclusion is supported by
another modelling study in which the importance of func-
tional dominance in inﬂuencing the rate of development
of resistance was  reduced as the proportion of the pop-
ulation escaping exposure to treatment increased (Wood
and Mani, 1981). It has also been suggested that there is
a threshold level for the proportion of a population which
ry Paras154 D.J. Bartram et al. / Veterina
must escape exposure to a pesticide for combinations to be
effective at delaying resistance (Roush, 1989).
Subsequent modelling of AR in sheep nematode indi-
cated that combinations profoundly slow the development
of resistance, even when resistance is functionally dom-
inant or partially dominant (Smith, 1990; Barnes et al.,
1995; Leathwick, 2011). This probably due to the small
proportions of the populations exposed to each treatment
and the normally rapid re-infection of treated animals with
susceptible larvae on pasture.
2.3. Low frequency of resistance alleles
The frequency of resistance alleles will vary enormously
between countries, farms, and even parasite species on a
farm (Leathwick et al., 2009). While combinations have the
greatest ability to slow AR development when resistance
genes are rare (Mani, 1985; Roush, 1989), computer mod-
elling of sheep nematode populations indicates that some
lesser beneﬁt can still be realised even when the level of
resistance to one of the component anthelmintics is rela-
tively high. In models simulating a derquantel–abamectin
combination, the development of resistance to derquantel,
for which the initial efﬁcacy was high, was delayed even
with a relatively low starting efﬁcacy of 50% for abamectin
(Leathwick, 2011). This is consistent with ﬁndings from
another modelling study (Dobson et al., 2011a)  in which a
BZ/LV combination was still effective in slowing the devel-
opment of resistance to other classes even when the initial
BZ resistance allele frequency was 40%. However, in the
ﬁeld trial described by Leathwick et al. (2011),  with ini-
tial efﬁcacies against Teladorsagia circumcincta for IVM and
LV of 69% and 65% respectively, the beneﬁt of an IVM + LV
combination was minimal. Practically, this means that the
best time to use a combination anthelmintic formulation is
before signiﬁcant resistance to one or more of the compo-
nent actives develops, or at least while the efﬁcacy of the
actives remains reasonably high.
2.4. Efﬁcacy of each of the component anthelmintics
against the susceptible genotypes approaches 100%
The dose rate of each anthelmintic in a combination
with an additive effect should be the same as that rec-
ommended when the anthelmintics are used separately.
The efﬁcacy of anthelmintics against susceptible strains of
most economically important parasites is generally high,
often 99–100%, when administered at the recommended
dose rates (Kistner et al., 1979; Kettle et al., 1981, 1982;
Preston, 1984; Echevarria et al., 1991). However, for all
anthelmintics, there are some nematode species against
which such high levels of efﬁcacy are not achieved. For
example, the efﬁcacy of derquantel against fourth stage
larvae (L4) of H. contortus and T. circumcincta, and adults
of the latter species is <95% (Little et al., 2010, 2011). Simi-
larly, the efﬁcacy of monepantel against L4 of Nematodirus
spathiger and adults of Oesophagostomum venulosum is
<95% (Hosking et al., 2009). Low efﬁcacy against some
nematodes does not necessarily mean increased selection
for resistance because a treatment which allows some
homozygous susceptible genotypes to survive can actuallyitology 186 (2012) 151– 158
slow the development of resistance (Barnes et al., 1995;
Smith et al., 1999). However, as the ability of one active to
protect other actives in a combination is dependent on its
efﬁcacy, an active with lower efﬁcacy would be expected
to be less protective than one which is more effective. Nev-
ertheless, model simulations indicate that an active with
reduced efﬁcacy against one or more nematode species is
still likely to be more effective at slowing resistance when
used in combination than when used alone in a sequential
or rotation strategy (D.M. Leathwick, unpublished data).
2.5. A proportion of the population is not exposed to
treatment to ensure that surviving resistant genotypes
are diluted in a pool of susceptible genotypes
In the control of pesticide resistance, the best approach
is to divide the population into an untreated segment
and another which is subjected to the maximum accept-
able doses of two or more pesticides in combination
(Comins, 1986), although this might be difﬁcult to achieve
due to factors such as uneven coverage of sprays. How-
ever, these concerns do not apply to the administration
of anthelmintics because one of the major differences
between the use of pesticides on crops and use of
anthelmintics against gastrointestinal nematode parasites
of livestock is that generally a large proportion of the pop-
ulation can escape treatment in the refugia on pasture.
Refugia are provided by: (1) free-living stages of nematodes
in the environment at the time of treatment; (2) any lifecy-
cle stage in the host which is refractory (but not resistant,
e.g. histotropic larvae) to a particular anthelmintic treat-
ment; and (3) nematodes residing in animals that are left
untreated (Fleming et al., 2006). In temperate climates, up
to 95% of the total worm population is free-living on pas-
ture and therefore escapes anthelmintic treatment (Barnes
et al., 1988), and this large proportion of the population
dilutes resistant genotypes surviving treatment. However,
in regions with hot, dry summers the proportion of free-
living worm stages will be lower because they rapidly
desiccate and die.
The effect of refugia on the rate of development of resis-
tance to anthelmintics used separately or in combination
in sheep grazing systems has been assessed using sev-
eral independent computer models (Dobson et al., 2011a,b;
Learmount et al., 2012). The models indicate that AR
develops more rapidly when anthelmintics are used in an
environment with little opportunity for survival of suscep-
tible nematodes, regardless of whether the anthelmintics
are used separately or in combination. A concern over the
use of combinations in such circumstances is the potential
to select for resistance to multiple chemical classes con-
currently, because only the worms that survive treatment
become the parents of the next generation (Besier, 2007).
Leathwick (2011) demonstrated that the level of efﬁcacy
required for one active in a combination to protect the
other active was higher in a low-refugia scenario than for
high-refugia. Nevertheless, this modelling showed that the
use of actives in combination was  always superior to using
them separately, either sequentially or in rotation, pro-
vided there were some nematodes in refugia (Leathwick,
2011).
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In situations where refugia are low, for example when
nfected sheep are moved after treatment onto pastures
ith low populations of infective larvae, or during cli-
atic conditions unfavourable to the survival of free-living
tages, refugia can be augmented by leaving a proportion
f the ﬂock untreated. Empirical studies (Waghorn et al.,
008, 2009) have demonstrated the potential of deliber-
tely created refugia to slow the development of AR, which
s consistent with the results of modelling studies which
ndicate that AR can be delayed when a proportion of
dult animals remain untreated (Leathwick et al., 2008;
obson et al., 2011a).  Several markers have been identi-
ed with potential to indicate those animals within a ﬂock
hat will most beneﬁt from treatment so that a proportion
f the others can remain untreated (Kenyon et al., 2009).
s AR increases, many more worms survive treatment and
he number of untreated animals required to substantially
ilute resistant genotypes (from treated animals) becomes
oo large and would compromise effective worm control
nd productivity. In this situation, the use of anthelmintics
n combination can reduce surviving resistant genotypes to
ery low numbers thereby exploiting the dilution provided
y parasites in refugia to greater effect.
.6. Anthelmintics in the combination have similar
uration of persistent action
The rationale for the active compounds used in com-
ination having similar duration of persistent activity is to
nsure that they are present together throughout the dura-
ion of efﬁcacy when administered concurrently (Curtis,
985; Roush, 1989). In this respect, one active cannot effec-
ively delay resistance to another active during any period
n which it continues to kill susceptible individuals after
he efﬁcacy of the other has expired (Roush, 1989).
Oral formulations of most anthelmintic classes have
imited persistent activity (Sutherland and Scott, 2010),
ith the exception of moxidectin (a ML)  which has sig-
iﬁcant activity against several parasite species for up to
5 days after treatment (Kerboeuf et al., 1995; Shoop et al.,
997) and closantel (a salicylanilide) which has persistent
ctivity against H. contortus (Hall et al., 1981). Ivermectin
hows only limited persistent activity against some species
or 3–5 days after treatment (McKenna, 1986; Borgsteede,
993; Shoop et al., 1997). Treatment with monepantel
an amino-acetonitrile derivative), at the recommended
ose, gives no protection against new infections of gas-
rointestinal nematodes (Stein et al., 2011) and the short
lasma half life of derquantel (a spiroindole) (European
edicines Agency, 2010) suggests that persistent activity
f this anthelmintic is unlikely. Thus, with the exception
f moxidectin and closantel, any difference in persistent
ctivity between anthelmintic classes when administered
rally is likely to be no more than a few days in duration
gainst most nematode species.
In Australia and New Zealand intra-ruminal capsules are
vailable which continuously release both albendazole and
bamectin, at below the normal therapeutic dose rate for an
ral treatment, for approximately 100 days. These products
ot only prevent the establishment of susceptible genotype
arvae for the duration of their payout but, because theyitology 186 (2012) 151– 158 155
are used in adult sheep at a time when acquired immu-
nity is returning after parturition, establishment of new
infection following the treatment period is low. Therefore,
these products probably fail to meet one of the most impor-
tant criteria for effectiveness of a combination at slowing
the development of resistance, i.e. the dilution of resistant
worms surviving treatment with newly established sus-
ceptible genotypes. They also appear to offer considerable
potential for linkage disequilibrium due to their prolonged
activity. Whether such products can be regarded as combi-
nations with a genuine ability to slow the development of
AR, as outlined above, remains unclear.
However, the mode of administration, formulation
and delivery mechanism have potential to profoundly
inﬂuence anthelmintic potency (Hennessy, 1997) and addi-
tionally, potential pharmacological interactions between
co-administered anthelmintics should be investigated
before their use can be advocated (Alvarez et al., 2008).
3. Nematode models
Models can be useful tools as an aid in understand-
ing the evolution of AR (Gaba and Silvestre, 2010), and
the potential of combinations to delay the development
of AR has been evaluated in several independent mod-
elling studies that simulate populations of nematodes of
sheep under ﬁeld conditions using environmental param-
eters and management strategies from different locations
(Smith, 1990; Barnes et al., 1995; Smith et al., 1999; Dobson
et al., 2011a,b; Leathwick, 2011; Learmount et al., 2012).
In contrast to insecticide models, nematode models con-
sistently indicate a signiﬁcant advantage to the use of
combinations over the use of single actives in delaying
AR development. This almost certainly reﬂects important
differences between the biology of the target organisms
and the patterns of use of the insecticide and anthelmintic
treatments that are reﬂected in the models. In the insec-
ticide models (Wood and Mani, 1981; Curtis, 1985; Mani,
1985; Roush, 1989), it is generally assumed that ≥90% of the
population is exposed to treatment during each applica-
tion. In the nematode models, anthelmintics are normally
applied to a relatively small proportion of a parasite pop-
ulation (<10%), with the remaining free-living stages and
parasites in untreated animals, receiving no exposure at all
(Smith, 1990).
While the rationale for the use of anthelmintics in
combination is intuitive (making it harder for a parasite
population to escape selection pressure by targeting mul-
tiple modes of action simultaneously) empirical data to
support this have proven difﬁcult to generate, given the
slow population dynamics and the lack of genetic mark-
ers to detect resistant traits (Gilleard and Beech, 2007).
Leathwick et al. (2011) attempted to evaluate empirically
the ﬁndings of computer model simulation of the use of
anthelmintics in combination. Twelve contiguous exper-
imental sites, each of four paddocks, were contaminated
with a mixture of resistant and susceptible isolates of T. cir-
cumcincta and Trichostrongylus colubriformis before being
stocked with lambs. Three replicates of four treatments
were applied in a 2 × 2 factorial design which com-
pared drench type (i.e. IVM vs. IVM/LV combination) and
ry Paras156 D.J. Bartram et al. / Veterina
proportion treated (i.e. 100% vs. 90% of lambs drenched
at each treatment). Resistance was monitored using larval
development assays and slaughter of treated and untreated
tracer lambs. In T. colubriformis, development of resistance
to IVM was delayed by the use of the combination and LV
resistance did not increase. In T. circumcincta, resistance
developed rapidly, apparently due to non-viability of the
susceptible isolate used to contaminate the pastures, but
nevertheless there was a measureable delay in the devel-
opment of resistance to IVM, although resistance to LV
increased.
4. Summary and conclusions
The use of combinations serves dual purposes
(Leathwick et al., 2009): (1) to maintain nematode
control in the presence of AR, sometimes involving more
than one parasite species and/or more than one class
of anthelmintic (Anderson et al., 1988; McKenna, 1990;
Anderson et al., 1991; Pomroy et al., 1992; Bartley et al.,
2004, 2005; Entrocasso et al., 2008; Le Jambre et al., 2010);
and concurrently, (2) to delay the development of AR to
the component chemical classes in those species in which
resistance is not yet evident (Smith, 1990; McKenna,
1990; Barnes et al., 1995; Smith et al., 1999; Dobson et al.,
2011b; Leathwick, 2011; Learmount et al., 2012). Without
the use of combinations, some anthelmintic classes could
no longer be used on many farms, despite still being
highly effective against a large proportion of the parasite
species on these farms. Studies to date have shown that
the use of combinations provides more sustainable control
of sheep nematodes than using them separately, either
sequentially or in different patterns of rotation, and this
occurred, albeit to a lesser extent, even in the presence
of cross-resistance between the two anthelmintic classes
or moderate levels of pre-existing resistance to one of
the classes. The validity of nematode model simulations
is supported by empirical evidence – the results of a
3-year replicated ﬁeld study were consistent with model
simulations which reproduced the conditions of the trial
(Leathwick et al., 2011). Combinations delay resistance
by reducing the number of resistant genotypes which
survive treatment, because multiple alleles conferring
resistance to all the component anthelmintic classes must
be present in the same parasite for survival. This enhanced
efﬁcacy leads to greater dilution of resistant genotypes
by the unselected parasites in refugia, thus reducing the
proportion of resistant parasites available to mate with
other resistant adults that have survived treatment.
However, the use of combinations in resistance man-
agement is not a panacea and, like all anthelmintic
formulations, maximum beneﬁt will be realised when they
are introduced before resistance is detectable and when
they are used in accordance with contemporary guidelines
for the sustainable use of anthelmintics, such as ensur-
ing the availability of adequate parasite refugia. To ensure
quality, safety, efﬁcacy and legal compliance, it is important
that only authorised ﬁxed combination products that have
been developed in accordance with regulatory guidelinesitology 186 (2012) 151– 158
are used rather than mixtures of separate anthelmintic
products prepared on farm.
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